UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003477 |
|---|---|
| Receipt number | R000004207 |
| Scientific Title | Randomized phase 2 study of mFOLFOX6 plus bevacizumab versus modified OPTIMOX plus bevacizumab for metastatic colorectal cancer |
| Date of disclosure of the study information | 2010/04/12 |
| Last modified on | 2017/04/17 13:38:04 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/12 00:43:11 | ||
| 2 | Update | 2010/12/25 18:25:53 | TEL Name of person sending information Organization Division name Address |
|
| 3 | Update | 2011/04/12 17:49:10 | Condition Trial characteristics_1 |
|
| 4 | Update | 2011/04/12 17:50:25 | Blocking |
|
| 5 | Update | 2011/04/12 17:52:56 | Organization Organization Organization Institute Email1 |
|
| 6 | Update | 2012/04/12 13:07:26 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 7 | Update | 2013/04/30 21:28:10 | Organization1 |
|
| 8 | Update | 2013/11/08 08:25:29 | TEL Category of Funding Organization Email1 |
|
| 9 | Update | 2015/04/13 13:44:13 | Organization Organization |
|
| 10 | Update | 2016/04/12 12:46:16 | Name of primary person or sponsor Organization |
|
| 11 | Update | 2017/04/17 13:38:04 | Recruitment status |
